Kelly Culwell, Chief Medical Officer at Evofem Biosciences, Inc. (EVFM), sold 2,000 shares at $4.66 ($9K) on 2020-04-30, disclosed to the SEC on 2020-05-01.
Scheduled sale ($9k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.66 | 1,000 | $5K | 49.5% |
| 2 | $4.75 | 1,000 | $5K | 50.5% |
| Total | $4.71 avg | 2,000 | $9K | 100% |
| Filing → |
| EVFM | BUY | 2018-08-20 | $7K | — | Filing → |